Literature DB >> 12504051

Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?

Dirk Rades1, Amira Bajrovic, Winfried Alberti, Volker Rudat.   

Abstract

PURPOSE: Symptomatic vertebral hemangiomas are rare vascular lesions. Radiotherapy is the most common treatment. Because of a lack of information in the literature, uncertainty exists about the total radiation dose to be applied. METHODS AND MATERIALS: Individual data from our own and published patients with symptomatic vertebral hemangioma treated with radiotherapy alone were obtained. The data were pooled, and the impact of the total dose on complete pain relief was evaluated using the chi-square test. Because different single-fraction doses were used, the equivalent dose in 2-Gy fractions (EQD(2)) was used for the analysis.
RESULTS: Complete data could be obtained from 117 patients. Patients were categorized according to total dose (EQD(2)) into two groups of similar size (Group A: 20-34 Gy, n = 62; and Group B: 36-44 Gy, n = 55). Radiation-induced complete pain relief was achieved in 39% (24/62) of the patients in Group A and in 82% (45/55) of the patients in Group B. The difference was statistically significant (p = 0.003).
CONCLUSIONS: The data suggest a dose-effect relationship in the radiotherapy of symptomatic vertebral hemangiomas. We recommend a total radiation dose 36-40 Gy with a dose per fraction of 2.0 Gy.

Entities:  

Mesh:

Year:  2003        PMID: 12504051     DOI: 10.1016/s0360-3016(02)03734-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Surgery in extensive vertebral hemangioma: case report, literature review and a new algorithm proposal.

Authors:  Roberto Tarantino; Pasquale Donnarumma; Lorenzo Nigro; Roberto Delfini
Journal:  Neurosurg Rev       Date:  2015-02-27       Impact factor: 3.042

Review 2.  Lumbar vertebral haemangioma causing pathological fracture, epidural haemorrhage, and cord compression: a case report and review of literature.

Authors:  S Vinay; S K Khan; J R Braybrooke
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 3.  Radiation therapy for the treatment of benign vascular, skeletal and soft tissue diseases.

Authors:  A Montero Luis; R Hernanz de Lucas; A Hervás Morón; E Fernández Lizarbe; S Sancho García; C Vallejo Ocaña; A Polo Rubio; A Ramos Aguerri
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

4.  DEGRO guidelines for the radiotherapy of non-malignant disorders : part III: hyperproliferative disorders.

Authors:  M Heinrich Seegenschmiedt; Oliver Micke; Marcus Niewald; Ralph Mücke; Hans Theodor Eich; Jan Kriz; Reinhard Heyd
Journal:  Strahlenther Onkol       Date:  2015-03-10       Impact factor: 3.621

5.  Vertebral hemangiomas: common lesions with still many unknown aspects.

Authors:  Lorenzo Nigro; Pasquale Donnarumma
Journal:  J Spine Surg       Date:  2017-06

6.  [The significance of radiation therapy for symptomatic vertebral hemangiomas (SVH)].

Authors:  Reinhard Heyd; M Heinrich Seegenschmiedt; Dirk Rades; Cornelia Winkler; Hans T Eich; Frank Bruns; Georg Gosheger; Normann Willich; Oliver Micke
Journal:  Strahlenther Onkol       Date:  2010-07-29       Impact factor: 3.621

Review 7.  Lumbar vertebral hemangioma mimicking lateral spinal canal stenosis: case report and review of literature.

Authors:  Vasileios Syrimpeis; Vasileios Vitsas; Panagiotis Korovessis
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

8.  Radiotherapy for a benign cause of cauda equina compression in a known case of breast carcinoma.

Authors:  Neeraj Bhalla; David J Husband; Robin Pillay; Nicki Thorp
Journal:  BMJ Case Rep       Date:  2013-06-19

9.  Radiotherapy for vertebral hemangioma: the single-center experience of 80 patients.

Authors:  Rahmi Atil Aksoy; Melek Gamze Aksu; Aylin Fidan Korcum; Mine Genc
Journal:  Strahlenther Onkol       Date:  2022-03-12       Impact factor: 4.033

Review 10.  Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines.

Authors:  M H Seegenschmiedt; O Micke; R Muecke
Journal:  Br J Radiol       Date:  2015-05-08       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.